EGFR mutation detection in plasma of lung tumor patients to predict success in treatment with tyrosine kinase inhibitors in a routine clinical setting.

e20545Background: EGFR alterations can be detected in the plasma of lung cancer patients mutated in their tumor. But there has been no prospective report evaluating the efficacy of tyrosine kinase ...